Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1196.491 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1196.491/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.491 |
Version | 20210909 |
Status | active |
Date | 2021-09-09T01:00:51-04:00 |
Name | MediumDoseICSFormoterolPreparations |
Title | Medium Dose ICS Formoterol Preparations |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: This valueset contains oral inhaled corticosteroid preparations in combination with formoterol that are used for medium-dose single maintenance and reliever therapy (SMART) in asthmatic adults and children at least 4 years old.),(Data Element Scope: FHIR MedicationStatement.medicationCodeableConcept, MedicationRequest.medicationCodeableConcept),(Inclusion Criteria: Includes oral ICS-formoterol preparations that might reasonably be used to treat asthmatic children age 4+ years and adults with daily and PRN combination medium-dose ICS-formoterol as per Step 4 in the NHLBI NAEPP 2020 Focused Updates to the Asthma Management Guidelines. The medium-dose range refers to the ICS component as per the NHLBI NAEPP EPR3 Guidelines for the Diagnosis and Management of Asthma (2007). Maintenance ICS ranges are different for age 12+ yrs vs. younger asthmatics, but medium-dose ranges are easily satisfied with the included preparations, which include formoterol in combination with budesonide 160 mcg/actuation (0.16 mg/actuation) and formoterol in combination with mometasone 200 mcg/actuation (0.2 mg/actuation).),(Exclusion Criteria: Excludes withdrawn preparations and retired codes (although they may still be available from pharmacies until supplies are exhausted); excludes low-dose oral ICS-formoterol preparations that are less likely to be used to treat asthmatics age 4+ in the medium-dose ranges as per the NHLBI NAEPP EPR3 Guidelines for the Diagnosis and Management of Asthma (2007).) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
No narrative content found in resource
{ "resourceType": "ValueSet", "id": "2.16.840.1.113762.1.4.1196.491", "meta": { "versionId": "11", "lastUpdated": "2023-12-21T17:43:03.000-05:00", "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ] }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-author", "valueContactDetail": { "name": "Elimu Informatics Author" } }, { "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate", "valueDate": "2025-03-10" }, { "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate", "valueDate": "2021-09-09" } ], "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.491", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113762.1.4.1196.491" } ], "version": "20210909", "name": "MediumDoseICSFormoterolPreparations", "title": "Medium Dose ICS Formoterol Preparations", "status": "active", "experimental": false, "date": "2021-09-09T01:00:51-04:00", "publisher": "NHLBI Implementation Science and Health Care Innovation Steward", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "US" } ] } ], "purpose": "(Clinical Focus: This valueset contains oral inhaled corticosteroid preparations in combination with formoterol that are used for medium-dose single maintenance and reliever therapy (SMART) in asthmatic adults and children at least 4 years old.),(Data Element Scope: FHIR \nMedicationStatement.medicationCodeableConcept, MedicationRequest.medicationCodeableConcept),(Inclusion Criteria: Includes oral ICS-formoterol preparations that might reasonably be used to treat asthmatic children age 4+ years and adults with daily and PRN combination medium-dose ICS-formoterol as per Step 4 in the NHLBI NAEPP 2020 Focused Updates to the Asthma Management Guidelines. The medium-dose range refers to the ICS component as per the NHLBI NAEPP EPR3 Guidelines for the Diagnosis and Management of Asthma (2007). Maintenance ICS ranges are different for age 12+ yrs vs. younger asthmatics, but medium-dose ranges are easily satisfied with the included preparations, which include formoterol in combination with budesonide 160 mcg/actuation (0.16 mg/actuation) and formoterol in combination with mometasone 200 mcg/actuation (0.2 mg/actuation).),(Exclusion Criteria: Excludes withdrawn preparations and retired codes (although they may still be available from pharmacies until supplies are exhausted); excludes low-dose oral ICS-formoterol preparations that are less likely to be used to treat asthmatics age 4+ in the medium-dose ranges as per the NHLBI NAEPP EPR3 Guidelines for the Diagnosis and Management of Asthma (2007).)", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "concept": [ { "code": "1246304", "display": "120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler" }, { "code": "1246306", "display": "120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort]" }, { "code": "1246311", "display": "120 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler" }, { "code": "1246313", "display": "120 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler [Dulera]" }, { "code": "1246316", "display": "60 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler" }, { "code": "1246317", "display": "60 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort]" }, { "code": "1660937", "display": "60 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler" }, { "code": "1660938", "display": "60 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler [Dulera]" } ] } ] }, "expansion": { "identifier": "urn:uuid:808fd908-4495-4ab4-af6e-5f8d2ab205cf", "timestamp": "2025-05-23T19:13:51-04:00", "total": 8, "contains": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1246304", "display": "120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1246306", "display": "120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1246311", "display": "120 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1246313", "display": "120 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler [Dulera]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1246316", "display": "60 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1246317", "display": "60 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1660937", "display": "60 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1660938", "display": "60 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler [Dulera]" } ] } }